ROC analyses confirmed the strong discriminatory power of MELTF, CRK, GSPT1, KPNA1, and MECP2 in distinguishing AML from healthy controls, underscoring their role as key biomarkers for AML susceptibility, especially in workers exposed to benzene. The gene discussed is KPNA1; the disease is acute myeloid leukemia.